Bal Pharma, an Indian pharmaceutical company, witnessed a rise in share price on Thursday after it announced the launch of its maiden OTC (over the counter) product 'Eye Spa', in Bangalore market.
"This is first among the series of OTC products that the company has lined up for launching in the market through its subsidiary i.e Lifezen Healthcare," Bal Pharma said.
Shares of Bal Pharma are trading at Rs 69.40, up Rs 1.8, or 2.66% at the Bombay Stock Exchange (BSE) on Thursday at 10:05 a.m.
Total volume of shares traded on the bourses today was higher by 546.53% to 13,863 compared with 22-day average volume of 2,144.